In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes a deep dive into the latest research on GLP1 medications and the lesser known side effects patients may experience. Drawing from new studies, clinical insights, and his own experience with GLP1 therapy, Dr. Sayed breaks down how these medications may influence anemia risk, micronutrient deficiencies, appetite changes, and overall metabolic health. He also explores new data on hemoglobin changes, iron intake, B12 levels, and nutritiona...
All content for The Scalpel's Edge is the property of Dr. Tim Sayed and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes a deep dive into the latest research on GLP1 medications and the lesser known side effects patients may experience. Drawing from new studies, clinical insights, and his own experience with GLP1 therapy, Dr. Sayed breaks down how these medications may influence anemia risk, micronutrient deficiencies, appetite changes, and overall metabolic health. He also explores new data on hemoglobin changes, iron intake, B12 levels, and nutritiona...
Ep. 8 - The Hidden Cost Of Ozempic: What You’re Not Being Told About Muscle Loss, Motivation & Metabolism
The Scalpel's Edge
14 minutes
8 months ago
Ep. 8 - The Hidden Cost Of Ozempic: What You’re Not Being Told About Muscle Loss, Motivation & Metabolism
In this eye-opening episode of The Scalpel’s Edge, double board-certified plastic surgeon Dr. Tim Sayed pulls back the curtain on the dark side of GLP-1 drugs like Ozempic and semaglutide. While these medications are hailed for their dramatic weight loss results, Dr. Sayed explores the less-discussed truth—up to 40% of that weight loss may actually be muscle mass. He dives into the science behind this phenomenon, the rising role of peptides like ipamorelin, and biotech innovations like myosta...
The Scalpel's Edge
In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes a deep dive into the latest research on GLP1 medications and the lesser known side effects patients may experience. Drawing from new studies, clinical insights, and his own experience with GLP1 therapy, Dr. Sayed breaks down how these medications may influence anemia risk, micronutrient deficiencies, appetite changes, and overall metabolic health. He also explores new data on hemoglobin changes, iron intake, B12 levels, and nutritiona...
